Rheumatology

A wearable device reduced fatigue and Raynaud symptoms in systemic sclerosis, improving quality of life without adverse effects.

A study revealed that early menopause and fewer reproductive years significantly increase the risk of ACPA-negative inflammatory arthritis.

A new Japanese retrospective study confirms that avacopan can effectively induce and sustain remission in patients with ANCA-associated vasculitis, reducing the need for glucocorticoids.

A new study revealed that adding urine alkalization therapy to febuxostat treatment in gout patients with low urinary pH leads to fewer flares, improved kidney health, and better lipid profiles.

A new machine learning model, CAPI-Detect, has demonstrated over 90% accuracy in diagnosing systemic sclerosis (SSc) using nailfold videocapillaroscopy (NVC).

A new study suggests that menopausal hormone therapy (MHT) may increase the risk of systemic lupus erythematosus and systemic sclerosis.

Secukinumab shows high drug survival and sustained effectiveness in psoriatic arthritis patients, with better outcomes in mixed peripheral and axial involvement.

A study of over 1,700 psoriatic arthritis patients across nine European countries reveals that tumor necrosis factor inhibitors (TNFi) work differently depending on the affected joint.